Daily cannabis and hemp policy intelligence - summarized, clarified, and delivered by a former regulator.
Feb 9, 2026
Daily quick briefs start today. We’re tracking FDA deadlines, antitrust risk, revenue pressure, and where enforcement is quietly tightening across markets.
Feb 6, 2026
Low-dose is becoming the mainstream playbook. Gun rights litigation keeps moving. States are choosing between repair plans and crackdowns.
Feb 5, 2026
Ohio races the clock to suspend SB 56, a federal court tightens 280E relief exposure, and hemp policy keeps widening the uncertainty gap from CBD to drinks.
Feb 4, 2026
Oklahoma’s repeal rhetoric collides with years of cleanup work, rescheduling starts showing up in insurance math, and Pennsylvania tries to legalize through the budget lane with a steep entry fee.
Feb 3, 2026
A quiet federal deadline carries loud restructuring consequences, and states are already aligning on hemp and safety rules. Plus our Clinical Therapeutics commentary on medical cannabis standards.
Feb 2, 2026
Michigan puts the lab lane on notice. Colorado’s vape questions tighten the supply chain story. Ohio’s hemp beverage ban hits in March, with Congress still debating the national THC math.
Jan 30, 2026
Rescheduling talk keeps running ahead of paperwork. Virginia races toward a legal market. Ohio and South Carolina tighten the hemp lane.
Jan 29, 2026
Massachusetts rewrites market mechanics in conference. DEA chatter needs institutional proof. Oklahoma links illicit grows to cleanup costs and budget muscle.
